celecoxib/tramadol

General

High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.

**REMS Drug**

Genetic Implications: Genetic Implications

**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.

Pronunciation:
sel-e-kox-ib/tra-ma-dol

Trade Name(s)

  • Seglentis

Ther. Class.

opioid analgesics

Pharm. Class.

cox 2 inhibitors

opioid agonists

Controlled Substance Schedule: IV

There's more to see -- the rest of this topic is available only to subscribers.